This article contains content that is written like an advertisement. Please help improve it by removing promotional content and inappropriate external links, and by adding encyclopedic content written from a neutral point of view.(February 2022) (Learn how and when to remove this message)
WuXi Biologics
WuXi Biologics Headquarters in Shanghai (2021 Construction)
WuXi Biologics is a global Contract Research Development and Manufacturing Organization (CRDMO) that provides open-access, integrated technology platforms for biologics drug development.
WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing.[5] WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017.[6]
As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore.[7]
In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong.[8]
In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns.[9][10][11] The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy.[12] Members of the United States House Select Committee on Strategic Competition between the United States and the Chinese Communist Party subsequently called for sanctions against WuXi Biologics.[13]
^"Leadership". WuXi Biologics. Archived from the original on 2020-12-02. Retrieved 2020-12-06.
^"Annual Financial Reports". WuXi Biologics. Archived from the original on 2020-12-02. Retrieved 2020-12-06.
^"WuXi Vaccines Overviewlanguage=en-US". Archived from the original on 2020-12-03. Retrieved 2020-12-06.
^"WuXi Biologics to acquire CMAB Biopharma Grouplanguage=en-US". Retrieved 2021-03-18.
^"CHNA ETF Video Series: WuXi Biologics". loncarfunds.com. Archived from the original on 2019-08-14. Retrieved 2019-08-14.
^"UPDATE 2-WuXi Biologics prices HK IPO at top as investors seek..." Reuters. 2017-06-06. Archived from the original on 2019-08-14. Retrieved 2019-08-14.
^"Global Network". WuXi Press Release. 2020-12-06. Archived from the original on 2020-12-02. Retrieved 2020-12-06.
^"Alibaba, Xiaomi, WuXi Biologics to join Hang Seng Index". S&P Global Market Intelligence. 2020-12-06. Archived from the original on 2023-01-10. Retrieved 2020-12-06.
^"WuXi Bio Denies Military Ties After Shares Slumped on US Bill". Bloomberg News. 2024-01-29. Archived from the original on 2024-01-29. Retrieved 2024-01-30.
^"WuXi AppTec Shares Continue Slide After Company Calls U.S. Draft Bill Findings Inaccurate". The Wall Street Journal. January 28, 2024. Archived from the original on January 29, 2024. Retrieved January 29, 2024.
^"WuXi Company Shares Tumble on U.S. Bill Aimed at Chinese Biotech". The Wall Street Journal. February 2, 2024. Archived from the original on February 1, 2024. Retrieved February 2, 2024.
^Cheung, Sunny; Hope, Arran; Mattis, Peter (February 9, 2024). "Red Genes: Assessing WuXi AppTec's Ties to the Party-Army-State in China". Jamestown Foundation. Archived from the original on 2024-02-10. Retrieved 2024-02-11.
^Martina, Michael (February 12, 2024). "US lawmakers call for sanctions on China's WuXi AppTec biotech firm". Reuters. Retrieved February 12, 2024.
for biologics drug development. WuXiBiologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery...
biological research and drug discovery. In 2012, WuXi AppTec opened a chemistry facility in Wuhan and a GMP biologics drug-substance facility in Wuxi...
Billionaire Zhao Ning Dies At 56 After Battling Cancer For 20 Years". Forbes. "Obituary – Mourning the Passing of Dr. Ning Zhao". WuxiBiologics. 17 May 2023....
2021, sotrovimab's active pharmaceutical ingredient was produced by WuXiBiologics in China and sent to a GlaxoSmithKline plant in Parma, Italy for further...
August 2020. Kennedy, John (23 May 2019). "Construction begins on €325m WuXiBiologics plant in Dundalk". siliconrepublic.com. Archived from the original on...
motives. Manipulative and duplicitous in nature. Zhang Yi Xi as Xiao Lu Historical prototype: Wu Ze Tian (武则天) A maid at befriends Fu Rou. Later becomes...
Emperor Wu of Jin (simplified Chinese: 晋武帝; traditional Chinese: 晉武帝; pinyin: Jìn Wǔ Dì; Wade–Giles: Chin Wu-Ti; 236 – 16 May 290), personal name Sima...
after the wedding—leading to theories that Cao Rui was actually biologically Yuan Xi's son and not Cao Pi's. However, Cao Cao was fond of this grandson...
Neurodegenerative disorders Stem cell marker SUMO protein WuXi PharmaTech Acquires Abgent, a Leading Producer of Biological Research Reagents. Oct 14, 2011. Technology...
Yu (17th century), Lingnan by Wu Zhen Fang (Qing Dynasty), in Nanyue Miscellanies by Li Diao Yuan, and others. Biological control techniques as we know...
愾 "hate" with the "heart-mind radical" 忄or 心, xì 熂 "set fire to weeds" with the "fire radical" 火, and xì 餼 "to present food" with the "food radical" 食...
2015 Chinese television series starring William Chan, Zhao Liying and Nicky Wu. It is adapted from the novel Legend of the Swordsmen of the Mountains of...
Participation in the International Biological Program, Report No. 6 of the U.S. National Committee for the International Biological Program. Senior Editor for...
Zhao (ed.). 吳書 [Book of Wu] (official history). Xi Zuochi. Han–Jin Chunqiu 漢晉春秋 [Chronicle of Han and Jin] (private history). Xi Zuochi (300s). Xiangyang...
protecting Outworld from Kronika's forces. Liu Kang and Kung Lao investigate the Wu Shi Academy and encounter Kronika's right-hand man, Geras. Their battle ends...
kung fu. He battled Tai Lung in combat and defeats him using the legendary Wuxi Finger Hold technique and is declared a master. In Kung Fu Panda 2, Po learns...
that the former emperor may try to return to the throne, had him exiled to Wu (吳縣, in modern Suzhou, Jiangsu) and put under heavy guard. In winter 372,...
Global Information
